Selected Grants
Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Recombinant Human Nerve Growth Factor Eye Drop Solution in Participants With Persistent Corneal Epithelial Defect (PCED)
Clinical TrialPrincipal Investigator · Awarded by Dompe farmaceutici S.p.A. · 2026 - 2031External Relationships
- Alcon Inc.
- Bausch & Lomb, Inc.
- BioTissue/Amniox
- Dompe
- Foster Ocular Immunology Society
- Iolyx
- Johnson & Johnson
- Keratoplasty Alliance International
- Novaliq
- Thea
- Up-to-date
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.